Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Interferon Sciences licenses novel approach for prevention of tumor recurrence

May 22, 2001

Preclinical studies support further testing of noscapine in malignant melanoma

May 22, 2001

Interim results of two Revimid studies presented at Myeloma Workshop

May 22, 2001

ETA antagonist delays disease progression, improves quality of life in late-stage prostate cancer

May 22, 2001

Novel inhibitors of alphav integrin receptors discovered by Amgen team

May 21, 2001

Abarelix as a new hormonal therapy for safely inducing medical castration in prostate cancer

May 21, 2001

ASCO presentation documents safety of TLK-286 over wide dose range, efficacy in advanced cancer

May 21, 2001

GTI-2040 safe and well tolerated in initial dose-escalating trial

May 21, 2001

Replication-competent virus for i.v. administration tested in cancer patients

May 21, 2001

P&G discovers new hydroxamic acid-based MMP inhibitors

May 18, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...